RiverVest Closes Raise of $184.4 Million on Fourth Life Sciences Fund

Fund IV was oversubscribed.

Life sciences venture capital firm RiverVest Venture Partners has announced the final closing of RiverVest Venture Fund IV, L.P., reaching $184.4 million in capital commitments in an oversubscribed fundraise. RiverVest Fund IV marks the firm’s fourth dedicated life sciences fund, bringing its total assets under management as of Sept. 30 to $753 million.

β€œSince its initial closing late last year, RiverVest Venture Fund IV has invested in eight high potential companies, including founding or co-founding three,” said RiverVest Managing Director John McKearn, Ph.D.

Earlier RiverVest Funds II and III have each provided net internal rates of return to their Limited Partners of over 20% per annum as of Sept. 30. That puts those funds’ performance in the top 5% of all venture funds started in the same respective vintage years according to Cambridge Associates’ U.S. Venture Capital Index, which benchmarks over 1,500 institutional-quality venture capital funds.

β€œWe are pleased that Fund IV exceeded our target,” said RiverVest co-founder and managing director Jay Schmelter. β€œIt enables us to continue executing our strategy for generating top-quartile investor returns.”

Schmelter credits RiverVest’s success to the firm’s dual focus on developing biopharma and medical device products that treat high, unmet medical needs while simultaneously attracting a buyer or being ready for an IPO within three to five years of the initial investment.

Mentioned in this Article

blank
Stories published by EQ Staff indicate that the article is based on a press release that's been sent to the editorial team via EQ's submit a press release for consideration form. Check the EQ IQ score on every article to determine how much due diligence took place. Press release submissions are not guaranteed placements and are selected for publishing on a merit basis. Feel free to drop us a line to learn more or if you have any questions.

πŸš€ Startup Funding News

Balto Raises $37.5M in Series B Funding

$1.5 Million Fund Raised to Invest in Latinx and Black Business Owners in St. Louis

🏎️ Startup Accelerator News

1ST50K Grant Competition Finalists Head to Cape Girardeau

No STL Startups Join Wells Fargo Innovation Incubator in 2021